Literature DB >> 25597840

Diet in the pathogenesis and treatment of inflammatory bowel diseases.

Dale Lee1, Lindsey Albenberg1, Charlene Compher1, Robert Baldassano1, David Piccoli1, James D Lewis2, Gary D Wu3.   

Abstract

Some of the most common symptoms of the inflammatory bowel diseases (IBD, which include ulcerative colitis and Crohn's disease) are abdominal pain, diarrhea, and weight loss. It is therefore not surprising that clinicians and patients have wondered whether dietary patterns influence the onset or course of IBD. The question of what to eat is among the most commonly asked by patients, and among the most difficult to answer for clinicians. There are substantial variations in dietary behaviors of patients and recommendations for them, although clinicians do not routinely endorse specific diets for patients with IBD. Dietary clinical trials have been limited by their inability to include a placebo control, contamination of study groups, and inclusion of patients receiving medical therapies. Additional challenges include accuracy of information on dietary intake, complex interactions between foods consumed, and differences in food metabolism among individuals. We review the roles of diet in the etiology and management of IBD based on plausible mechanisms and clinical evidence. Researchers have learned much about the effects of diet on the mucosal immune system, epithelial function, and the intestinal microbiome; these findings could have significant practical implications. Controlled studies of patients receiving enteral nutrition and observations made from patients on exclusion diets have shown that components of whole foods can have deleterious effects for patients with IBD. Additionally, studies in animal models suggested that certain nutrients can reduce intestinal inflammation. In the future, engineered diets that restrict deleterious components but supplement beneficial nutrients could be used to modify the luminal intestinal environment of patients with IBD; these might be used alone or in combination with immunosuppressive agents, or as salvage therapy for patients who do not respond or lose responsiveness to medical therapies. Stricter diets might be required to induce remission, and more sustainable exclusion diets could be used to maintain long-term remission.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet; IBD; Pathogenesis; Therapy

Mesh:

Year:  2015        PMID: 25597840      PMCID: PMC4409494          DOI: 10.1053/j.gastro.2015.01.007

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  143 in total

Review 1.  Enteral nutritional therapy for induction of remission in Crohn's disease.

Authors:  M Zachos; M Tondeur; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Managing cows' milk allergy in children.

Authors:  Sian Ludman; Neil Shah; Adam T Fox
Journal:  BMJ       Date:  2013-09-16

3.  Prevalence of ulcerative colitis in the Israeli kibbutz population.

Authors:  Y Niv; G Abukasis
Journal:  J Clin Gastroenterol       Date:  1991-02       Impact factor: 3.062

4.  Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme.

Authors:  Elise M J van der Logt; Tjasso Blokzijl; Roelof van der Meer; Klaas Nico Faber; Gerard Dijkstra
Journal:  J Nutr Biochem       Date:  2012-12-12       Impact factor: 6.048

5.  Hyperalimentation in inflammatory bowel disease.

Authors:  J Reilly; J A Ryan; W Strole; J E Fischer
Journal:  Am J Surg       Date:  1976-02       Impact factor: 2.565

Review 6.  Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective.

Authors:  Jonathan D Nolan; Ian M Johnston; Julian R F Walters
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-01       Impact factor: 3.869

7.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

8.  Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages.

Authors:  Ayatoshi Andou; Tadakazu Hisamatsu; Susumu Okamoto; Hiroshi Chinen; Nobuhiko Kamada; Taku Kobayashi; Masaki Hashimoto; Tomohisa Okutsu; Kazutaka Shimbo; Tomoko Takeda; Hideki Matsumoto; Atsushi Sato; Hiroshi Ohtsu; Manabu Suzuki; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

10.  Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.

Authors:  Enrique Alcalde-Cabero; Javier Almazán-Isla; Antonio García-Merino; Joao de Sá; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2013-06-12       Impact factor: 2.474

View more
  108 in total

1.  Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?

Authors:  Dale Lee; David Suskind
Journal:  Dig Dis Sci       Date:  2016-04       Impact factor: 3.199

2.  Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.

Authors:  David L Suskind; Ghassan Wahbeh; Stanley A Cohen; Christopher J Damman; Jani Klein; Kim Braly; Michele Shaffer; Dale Lee
Journal:  Dig Dis Sci       Date:  2016-09-16       Impact factor: 3.199

Review 3.  Indole compounds may be promising medicines for ulcerative colitis.

Authors:  Shinya Sugimoto; Makoto Naganuma; Takanori Kanai
Journal:  J Gastroenterol       Date:  2016-05-09       Impact factor: 7.527

Review 4.  The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Authors:  James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

5.  Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn's Disease.

Authors:  Warapan Nakayuenyongsuk; Megan Christofferson; Kaylie Nguyen; Jennifer Burgis; K T Park
Journal:  Dig Dis Sci       Date:  2017-10       Impact factor: 3.199

6.  Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Authors:  Sandeep A Walujkar; Shreyas V Kumbhare; Nachiket P Marathe; Dhrati V Patangia; Parimal S Lawate; Renu S Bharadwaj; Yogesh S Shouche
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

Review 7.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

Review 8.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.

Authors:  John B Grigg; Gregory F Sonnenberg
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

Review 9.  Diagnosis and management of inflammatory bowel disease in children.

Authors:  Stephanie B Oliveira; Iona M Monteiro
Journal:  BMJ       Date:  2017-05-31

Review 10.  Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.

Authors:  Marla Dubinsky; Jonathan Braun
Journal:  Gastroenterology       Date:  2015-08-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.